Of all of the biotech's I hold - vla has the most cash in the bank. And now they go and raise another $30m!
And this is straight after the tax refund - which more than covered the whole of last quarter's spend.
However, I much prefer to have a biotech with too much money in the bank than not enough. That's always a disaster.
It also strengthens vla's bargaining position during a deal or takeover.
Cheers
$30m expected raising, page-29
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)